Correlation Between Korea Refractories and AptaBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Korea Refractories and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korea Refractories and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Korea Refractories Co and AptaBio Therapeutics, you can compare the effects of market volatilities on Korea Refractories and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korea Refractories with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korea Refractories and AptaBio Therapeutics.
Diversification Opportunities for Korea Refractories and AptaBio Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Korea and AptaBio is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Korea Refractories Co and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and Korea Refractories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korea Refractories Co are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of Korea Refractories i.e., Korea Refractories and AptaBio Therapeutics go up and down completely randomly.
Pair Corralation between Korea Refractories and AptaBio Therapeutics
Assuming the 90 days trading horizon Korea Refractories Co is expected to under-perform the AptaBio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Korea Refractories Co is 1.5 times less risky than AptaBio Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The AptaBio Therapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 1,085,000 in AptaBio Therapeutics on October 9, 2024 and sell it today you would lose (382,000) from holding AptaBio Therapeutics or give up 35.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Korea Refractories Co vs. AptaBio Therapeutics
Performance |
| Timeline |
| Korea Refractories |
| AptaBio Therapeutics |
Korea Refractories and AptaBio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Korea Refractories and AptaBio Therapeutics
The main advantage of trading using opposite Korea Refractories and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korea Refractories position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.| Korea Refractories vs. Fine Besteel Co | Korea Refractories vs. Hankuk Steel Wire | Korea Refractories vs. Dong A Steel Technology | Korea Refractories vs. TS Investment Corp |
| AptaBio Therapeutics vs. ABL Bio | AptaBio Therapeutics vs. Helixmith Co | AptaBio Therapeutics vs. OliX PharmaceuticalsInc | AptaBio Therapeutics vs. Oscotec |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |